Search Virginia Mason News


This year Benaroya Research Institute at Virginia Mason (BRI) is celebrating 50 years of scientific innovation and advancements to improve people’s lives. BRI works to unlock the mysteries of the immune system. Its team of world-renowned scientists is focused on identifying causes and cures for devastating diseases including diabetes, arthritis, heart disease and cancer. BRI is an international leader in immune system and autoimmune disease research with a focus on translating laboratory discoveries to real life applications.

Our History
First established in l956 as the Virginia Mason Research Center, Benaroya Research Institute at Virginia Mason developed a unique niche as a basic sciences research institute associated with a major medical center and teaching program. Renamed in 2002 in recognition of the support of the Benaroya family of Seattle, BRI is at the forefront of translational research, an approach that brings together advances in discovery-based science and clinical treatment to benefit patients affected by disease.

BRI includes 200 scientific staff, represented by six major program areas: Diabetes, Immunology, Molecular Genetics, Hope Heart Program, Translational Research and Clinical Research. BRI operates on $20 million annually, funded through research grants awarded by the National Institutes of Health, the Juvenile Diabetes Research Foundation, the National Cancer Institute, the American Heart Association, and a variety of other national and regional foundations, as well as by individual philanthropic gifts.

Benaroya Research Institute at Virginia Mason
Back to Search